# Silence Therapeutics plc: filings

SLN · Nasdaq · CIK 1479615 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/sln.md) · [Financials](/companies/sln/financials.md) · [Filings](/companies/sln/filings.md) · [Insiders](/companies/sln/insiders.md)

## Reports and events: 116 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 67, 4 42, 8-K 21, 3 10, EFFECT 10, SC 13G 10, SC 13G/A 10, UPLOAD 8, CORRESP 7, SCHEDULE 13D/A 7, 10-Q 5, 424B5 5, POS AM 5, SCHEDULE 13G/A 5, 20-F 4, D 4, S-8 4, SC 13D/A 4, 424B4 3, 10-K 2, 6-K/A 2, 8-K/A 2, ARS 2, DEF 14A 2, DEFA14A 2, F-1 2, F-1/A 2, F-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-K/A 1, 20-F/A 1, 424B3 1, 424B7 1, 8-A12B 1, CERT 1, DEL AM 1, DRS 1, DRS/A 1, DRSLTR 1, F-3ASR 1, PRE 14A 1, S-3 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 12:05 ET | [8-K](/filings/0001193125-26-424695.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-424695 |
| 2026-08-13 | 01:55 ET | [SCHEDULE 13D/A](/filings/0001104659-26-096202.md) | Ownership report, active investor, amended | 0001104659-26-096202 |
| 2026-08-12 | 21:23 ET | [8-K](/filings/0001193125-26-347196.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347196 |
| 2026-08-10 | 11:57 ET | [8-K](/filings/0001193125-26-341293.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-341293 |
| 2026-08-10 | 11:26 ET | [10-Q](/filings/0001193125-26-341248.md) | Quarterly report, period 2026-06-30 | 0001193125-26-341248 |
| 2026-08-10 | 11:20 ET | [8-K](/filings/0001193125-26-341240.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341240 |
| 2026-07-16 | 21:20 ET | [8-K/A](/filings/0001193125-26-306251.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-306251 |
| 2026-07-08 | 11:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-081559.md) | Ownership report, active investor, amended | 0001104659-26-081559 |
| 2026-06-23 | 20:35 ET | [8-K](/filings/0001193125-26-279577.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-279577 |
| 2026-06-16 | 21:00 ET | [8-K](/filings/0001193125-26-272814.md) | 5.07 Shareholder vote results | 0001193125-26-272814 |
| 2026-06-11 | 11:35 ET | [8-K](/filings/0001193125-26-266705.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-266705 |
| 2026-05-18 | 21:00 ET | [8-K](/filings/0001193125-26-229089.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229089 |
| 2026-05-07 | 12:22 ET | [10-Q](/filings/0001193125-26-210446.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210446 |
| 2026-05-07 | 12:15 ET | [8-K](/filings/0001193125-26-210428.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210428 |
| 2026-04-29 | 20:23 ET | [DEF 14A](/filings/0001193125-26-191786.md) | Proxy statement, period 2026-06-16 | 0001193125-26-191786 |
| 2026-03-05 | 12:49 ET | [10-K](/filings/0001193125-26-092591.md) | Annual report, period 2025-12-31 | 0001193125-26-092591 |
| 2026-03-05 | 12:40 ET | [8-K](/filings/0001193125-26-092578.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-092578 |
| 2025-12-22 | 21:01 ET | [8-K/A](/filings/0001193125-25-328684.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-328684 |
| 2025-12-22 | 12:32 ET | [8-K](/filings/0001193125-25-327575.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-327575 |
| 2025-12-15 | 21:01 ET | [8-K](/filings/0001193125-25-319156.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-319156 |
| 2025-11-06 | 12:53 ET | [10-Q](/filings/0001193125-25-268116.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268116 |
| 2025-11-06 | 12:38 ET | [8-K](/filings/0001193125-25-268102.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268102 |
| 2025-10-23 | 11:45 ET | [8-K](/filings/0001193125-25-247692.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-247692 |
| 2025-08-14 | 10:30 ET | [8-K](/filings/0001193125-25-180313.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-180313 |
| 2025-08-07 | 12:04 ET | [10-Q](/filings/0000950170-25-104593.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104593 |
| 2025-08-07 | 11:35 ET | [8-K](/filings/0001193125-25-174958.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174958 |
| 2025-06-27 | 11:00 ET | [8-K](/filings/0001193125-25-149704.md) | 5.07 Shareholder vote results | 0001193125-25-149704 |
| 2025-06-25 | 14:24 ET | [SCHEDULE 13D/A](/filings/0001104659-25-062458.md) | Ownership report, active investor, amended | 0001104659-25-062458 |
| 2025-05-16 | 10:05 ET | [DEF 14A](/filings/0001193125-25-121232.md) | Proxy statement, period 2025-06-26 | 0001193125-25-121232 |
| 2025-05-08 | 14:18 ET | [SCHEDULE 13D/A](/filings/0001104659-25-045969.md) | Ownership report, active investor, amended | 0001104659-25-045969 |
| 2025-05-08 | 12:35 ET | [10-Q](/filings/0000950170-25-066439.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066439 |
| 2025-05-08 | 12:10 ET | [8-K](/filings/0001193125-25-115533.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115533 |
| 2025-05-06 | 12:03 ET | [8-K](/filings/0001193125-25-113364.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-113364 |
| 2025-04-30 | 20:30 ET | [10-K/A](/filings/0000950170-25-061116.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-061116 |
| 2025-04-24 | 13:28 ET | [SCHEDULE 13D/A](/filings/0001104659-25-038392.md) | Ownership report, active investor, amended | 0001104659-25-038392 |
| 2025-03-31 | 14:50 ET | [SCHEDULE 13D/A](/filings/0001104659-25-029716.md) | Ownership report, active investor, amended | 0001104659-25-029716 |
| 2025-02-27 | 21:30 ET | [10-K](/filings/0000950170-25-029129.md) | Annual report, period 2024-12-31 | 0000950170-25-029129 |
| 2025-02-27 | 21:13 ET | [8-K](/filings/0001193125-25-039248.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-039248 |
| 2025-01-02 | 13:00 ET | [8-K](/filings/0001193125-25-000144.md) | 7.01 Regulation FD disclosure | 0001193125-25-000144 |
| 2024-12-20 | 22:32 ET | [SCHEDULE 13D/A](/filings/0001104659-24-130924.md) | Ownership report, active investor, amended | 0001104659-24-130924 |
| 2024-12-09 | 13:12 ET | [6-K](/filings/0001193125-24-272929.md) | Report of a foreign private issuer, period 2024-12-09 | 0001193125-24-272929 |
| 2024-11-18 | 21:54 ET | [6-K](/filings/0001193125-24-260987.md) | Report of a foreign private issuer, period 2024-11-18 | 0001193125-24-260987 |
| 2024-11-14 | 14:24 ET | [6-K](/filings/0000950170-24-126791.md) | Report of a foreign private issuer, period 2024-09-30 | 0000950170-24-126791 |
| 2024-08-15 | 13:05 ET | [6-K](/filings/0000950170-24-097383.md) | Report of a foreign private issuer, period 2024-06-30 | 0000950170-24-097383 |
| 2024-06-27 | 11:40 ET | [6-K](/filings/0001193125-24-169739.md) | Report of a foreign private issuer, period 2024-06-27 | 0001193125-24-169739 |
| 2024-06-24 | 12:38 ET | [6-K](/filings/0001193125-24-166362.md) | Report of a foreign private issuer, period 2024-06-24 | 0001193125-24-166362 |
| 2024-06-20 | 12:41 ET | [6-K](/filings/0001193125-24-164042.md) | Report of a foreign private issuer, period 2024-06-20 | 0001193125-24-164042 |
| 2024-05-17 | 21:04 ET | [6-K](/filings/0001193125-24-141853.md) | Report of a foreign private issuer, period 2024-05-17 | 0001193125-24-141853 |
| 2024-05-16 | 18:21 ET | [6-K](/filings/0000950170-24-060977.md) | Report of a foreign private issuer, period 2024-03-31 | 0000950170-24-060977 |
| 2024-05-01 | 20:37 ET | [6-K](/filings/0001193125-24-127556.md) | Report of a foreign private issuer, period 2024-05-01 | 0001193125-24-127556 |

Page 1 of 3. [Older](/companies/sln/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.